{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:53Z","timestamp":1740136373709,"version":"3.37.3"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Apopharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10072-019-03791-w","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T14:24:13Z","timestamp":1551709453000},"page":"1947-1949","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ten years of iron chelation in a patient with superficial siderosis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7969-8346","authenticated-orcid":false,"given":"Michael","family":"Levy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"issue":"3","key":"3791_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ana.24850","volume":"81","author":"D Wilson","year":"2017","unstructured":"Wilson D, Chatterjee F, Farmer SF, Rudge P, McCarron MO, Cowley P, Werring DJ (2017) Infratentorial superficial siderosis: classification, diagnostic criteria, and rational investigation pathway. Ann Neurol 81(3):333\u2013343","journal-title":"Ann Neurol"},{"issue":"1","key":"3791_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ncpneuro0356","volume":"3","author":"M Levy","year":"2007","unstructured":"Levy M, Turtzo C, Llinas RH (2007) Superficial siderosis: a case report and review of the literature. Nat Clin Pract Neurol 3(1):54\u201358 quiz 59","journal-title":"Nat Clin Pract Neurol"},{"issue":"1","key":"3791_CR3","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3174\/ajnr.A2331","volume":"32","author":"M Levy","year":"2011","unstructured":"Levy M, Llinas RH (2011) Deferiprone reduces hemosiderin deposits in the brain of a patient with superficial siderosis. AJNR Am J Neuroradiol 32(1):E1\u2013E2","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"3791_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/cns.12792","volume":"24","author":"RA Kessler","year":"2018","unstructured":"Kessler RA, Li X, Schwartz K, Huang H, Mealy MA, Levy M (2018) Two-year observational study of deferiprone in superficial siderosis. CNS Neurosci Ther 24(3):187\u2013192","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"3791_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/STROKEAHA.111.628032","volume":"43","author":"M Levy","year":"2012","unstructured":"Levy M, Llinas R (2012) Pilot safety trial of deferiprone in 10 subjects with superficial siderosis. Stroke 43(1):120\u2013124","journal-title":"Stroke"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03791-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-03791-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03791-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T19:28:58Z","timestamp":1583177338000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-03791-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["3791"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-03791-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The patient provided informed consent to publish the details of his case.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}},{"value":"Dr. Levy previously received a research award from the manufacturer of Ferriprox (deferiprone), Apopharma Inc., to conduct a trial of deferiprone in superficial siderosis between 2014 and 2016.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}